{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:56:18Z","timestamp":1781553378542,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1207500"],"award-info":[{"award-number":["2022YFA1207500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013289","name":"Shenzhen Institutes of Advanced Technology Innovation Program for Excellent Young Researchers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030067"],"award-info":[{"award-number":["82030067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82250710174"],"award-info":[{"award-number":["82250710174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82161160342"],"award-info":[{"award-number":["82161160342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302757"],"award-info":[{"award-number":["82302757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.apsb.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T01:22:46Z","timestamp":1710120166000},"page":"2977-2991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-3457","authenticated-orcid":false,"given":"Ke","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9932-4210","authenticated-orcid":false,"given":"Siyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-2859","authenticated-orcid":false,"given":"Haiqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9347-5782","authenticated-orcid":false,"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.03.013_bib1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.apsb.2024.03.013_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-6-24","article-title":"The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention","volume":"6","author":"Alao","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2024.03.013_bib3","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1242\/jcs.039131","article-title":"Transcriptional regulation of the cyclin D1 gene at a glance","volume":"121","author":"Klein","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2024.03.013_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1101\/gad.11.8.957","article-title":"Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin\u2012proteasome pathway","volume":"11","author":"Diehl","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.apsb.2024.03.013_bib5","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/sj.onc.1208326","article-title":"Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis","volume":"24","author":"Guo","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2024.03.013_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.2910570311","article-title":"Cyclin D1 protein expression and function in human breast cancer","volume":"57","author":"Bartkova","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2024.03.013_bib7","first-page":"560","article-title":"Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene","volume":"8","author":"Zukerberg","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.apsb.2024.03.013_bib8","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2024.03.013_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q","article-title":"Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer","volume":"188","author":"Wagner","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.apsb.2024.03.013_bib10","first-page":"1891","article-title":"Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone","volume":"6","author":"Drobnjak","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.03.013_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2006.09.024","article-title":"Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation","volume":"55","author":"Gautschi","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.apsb.2024.03.013_bib12","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/1078-0432.CCR-08-3330","article-title":"A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases","volume":"15","author":"Ogino","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.03.013_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.03.013_bib14","doi-asserted-by":"crossref","first-page":"12074","DOI":"10.1074\/jbc.275.16.12074","article-title":"Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286","volume":"275","author":"Germain","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.03.013_bib15","doi-asserted-by":"crossref","first-page":"12555","DOI":"10.1074\/jbc.274.18.12555","article-title":"The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers","volume":"274","author":"Sternsdorf","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.03.013_bib16","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1210\/en.2002-220135","article-title":"Potentiation of glucocorticoid receptor transcriptional activity by sumoylation","volume":"143","author":"Le Drean","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2024.03.013_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbrc.2004.09.068","article-title":"Sumoylation increases HIF-1alpha stability and its transcriptional activity","volume":"324","author":"Bae","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2024.03.013_bib18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.molcel.2013.01.017","article-title":"Regulation of DNA damage responses by ubiquitin and SUMO","volume":"49","author":"Jackson","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2024.03.013_bib19","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1128\/MCB.02301-05","article-title":"The SUMO-specific protease SENP5 is required for cell division","volume":"26","author":"Di Bacco","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2024.03.013_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: a regulatory protein modification in health and disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2024.03.013_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/373078a0","article-title":"Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins","volume":"373","author":"Seufert","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.03.013_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc.2016.143","article-title":"SUMO and the robustness of cancer","volume":"17","author":"Seeler","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.03.013_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-genet-111212-133453","article-title":"Control of nuclear activities by substrate-selective and protein-group SUMOylation","volume":"47","author":"Jentsch","year":"2013","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.apsb.2024.03.013_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41467-021-27704-8","article-title":"Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma","volume":"13","author":"Schick","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.03.013_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/tx025615j","article-title":"Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity","volume":"16","author":"Samikkannu","year":"2003","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2024.03.013_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/tx050106d","article-title":"Arsenic toxicology: five questions","volume":"19","author":"Aposhian","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2024.03.013_bib27","first-page":"3065","article-title":"Arsenic trioxide-mediated growth inhibition in MC\/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.03.013_bib28","first-page":"3893","article-title":"Mechanisms of action of arsenic trioxide","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.03.013_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00277-013-1866-2","article-title":"Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1","volume":"93","author":"Lo","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.apsb.2024.03.013_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ncb1716","article-title":"RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation","volume":"10","author":"Tatham","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2024.03.013_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML","volume":"328","author":"Zhang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.03.013_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2024.03.013_bib33","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1016\/j.bmc.2008.03.054","article-title":"An improved synthesis of arsenic\u2012biotin conjugates","volume":"16","author":"Heredia-Moya","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2024.03.013_bib34","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M407349200","article-title":"Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression","volume":"279","author":"Newman","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.03.013_bib35","doi-asserted-by":"crossref","first-page":"43169","DOI":"10.1074\/jbc.M308009200","article-title":"WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation","volume":"278","author":"Magnifico","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.03.013_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature08011","article-title":"F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage","volume":"459","author":"Santra","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.03.013_bib37","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2018-02-832535","article-title":"SOX11 augments BCR signaling to drive MCL-like tumor development","volume":"131","author":"Kuo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2024.03.013_bib38","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1002\/chem.201300567","article-title":"Versatile probes for the selective detection of vicinal-dithiol-containing proteins: design, synthesis, and application in living cells","volume":"19","author":"Huang","year":"2013","journal-title":"Chemistry"},{"key":"10.1016\/j.apsb.2024.03.013_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02787360","article-title":"Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases","volume":"16","author":"Huang","year":"1999","journal-title":"Med Oncol"},{"key":"10.1016\/j.apsb.2024.03.013_bib40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nsmb1168","article-title":"Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates","volume":"13","author":"Reverter","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.apsb.2024.03.013_bib41","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.03.013_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","article-title":"Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice","volume":"369","author":"Wang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.03.013_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccr.2005.12.019","article-title":"Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis","volume":"9","author":"Landis","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2024.03.013_bib44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(20)30165-3","article-title":"Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future","volume":"395","author":"Spring","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.03.013_bib45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/MCB.20.2.672-683.2000","article-title":"Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway","volume":"20","author":"Lee","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2024.03.013_bib46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/35082500","article-title":"Specific protection against breast cancers by cyclin D1 ablation","volume":"411","author":"Yu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.03.013_bib47","article-title":"Calcineurin regulates cyclin D1 stability through dephosphorylation at T286","volume":"9","author":"Goshima","year":"2019","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.apsb.2024.03.013_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc.2017.103","article-title":"Differentiation therapy revisited","volume":"18","author":"de Th\u00e9","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.03.013_bib49","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/annonc\/mdu142","article-title":"Oral arsenic trioxide-based regimen as salvage treatment for relapsed or refractory mantle cell lymphoma","volume":"25","author":"Gill","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2024.03.013_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/91.9.772","article-title":"Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations","volume":"91","author":"Zhu","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2024.03.013_bib51","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1080\/10428190500215100","article-title":"Expression of cyclins D1, D2, and D3 and Ki-67 in leukemia","volume":"46","author":"Jaroslav","year":"2005","journal-title":"Leuk Lymphoma"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T03:10:37Z","timestamp":1720581037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524000947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2211383524000947"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.03.013","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}